Driverless Cars Are NOTHING Without This Crucial Tech...

For your weekend reading, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily… For your weekend reading, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily… [Energy and Capital logo] Driverless Cars Are NOTHING Without This Crucial Tech... [Keith Kohl Photo] By [Keith Kohl]( Written Dec 11, 2021 For your weekend reading, we bring you the week's most popular stories from [Energy and Capital]( and our sister site, [Wealth Daily](… [Apple Versus Tesla: How You Win]( See how Tim Cook plans to CRUSH Detroit and how you can profit from this legendary showdown. [Elon Musk Absolutely Hates This Tech]( Sure, electric vehicles play an important role in helping us transition away from fossil fuels, but the world may actually be moving away from EVs — and Elon Musk is furious... [The Most Misleading Chart of the Year]( We’re seeing the highest gas prices in a decade... the highest price surge in 30 years. It’s impossible to overstate the impact. [Pot Is About to Have Its "Bitcoin Moment"]( We’re at a historic turning point with the birth of America’s marijuana supply chain. For 111 million Americans, pot is already legal. Small, no-cash companies hiding in the shadows are vanishing. They’re being bought out in buyouts worth $1 billion or more, but there are three small pot companies in particular that are about to explode in value. [What's the Deal With the Metaverse?]( The metaverse is everywhere, and investors are betting big on this concept. In all directions, there are people snagging up opportunities to get a piece... The #1 Strategy for Biotech Stocks? It’s no secret that biotech is the most exciting investment arena there is. There’s never a shortage of demand for new treatments for the world’s worst diseases, like cancer, Alzheimer’s, and arthritis. And with my new trading system, “Project Greenlight,” you’ll always know with up to 95% confidence which of those new medicines will be approved by the FDA and which won’t... This could set investors up to make six figures or more in biotech profits. And right now, there's a tiny biotech firm trading for pennies on the dollar with a medicine that’s on the brink of FDA approval... [Learn more about this unique opportunity today.]( [Beware the Gravestone Doji]( I’m making the call. It's time to change your mindset from “buy the dips” to “sell the rips.” No one ever went broke taking a profit. [New Treatment Better Than the COVID Vaccine?]( This could be the medical breakthrough we’ve all been waiting for to finally end the pandemic once and for all. But the best part is that it’s not a vaccine. You can administer this virus-killing nasal spray treatment yourself in your own home! No more appointments, needles, or stress. In fact, it could be in every medicine cabinet in America very soon, and it has the potential to hand early investors massive profits. [The Crisis Nobody's Talking About]( There's a crisis nobody's talking about that could wreak far more havoc than anything else we've seen so far. But there's a way for prepared investors to profit from it, and Jason Williams wants to help. [Who Is Holding Back the COVID Cure?]( A new monoclonal antibody therapy could be the breakthrough we've all been waiting for. According to the world’s top epidemiologists, this is the only effective way to treat COVID-19 cases... [All of Silicon Valley Is Relying on This Small Firm's Patented Device]( There's a strange new type of technology that's secretly being tested on some of Tesla's newest cars, and it's about to completely revolutionize a $1.3 trillion market. Many Fortune 500 companies like General Motors, Caterpillar, and NVIDIA are already use this tech, and very soon every company in the world will be utilizing it. This tech could be a fortune-maker... because driverless cars are NOTHING without it. Until next time, [Keith Kohl Signature] Keith Kohl [[follow basic]@KeithKohl1 on Twitter]( A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of [Energy & Capital](, as well as the investment director of Angel Publishing's [Energy Investor]( and [Technology and Opportunity](. For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology. Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s [Topline Trader]( advisory newsletter. Browse Our Archives [The Most Misleading Chart of the Year]( [Beware the Gravestone Doji]( [Who Is Holding Back the COVID Cure?]( [It's Like a Black Friday Sale (This Stock Will Never Be This Cheap Again)]( [Only a Fool Would Invest in Coal]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here]( and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2021, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.]( ---------------------------------------------------------------